期刊文献+

新生儿肺炎患儿痰细菌培养检测及耐药分析

Sputum bacterial culture detection and drug resistance analysis of neonatal pneumonia
下载PDF
导出
摘要 目的:观察新生儿肺炎患儿痰病原菌的种类及耐药情况。方法:选取新生儿肺炎的患儿182例进行负压吸痰;将痰液细菌进行培养及药物敏感试验,并对常见病原微生物进行病原学分析。结果:182例新生儿肺炎的患儿痰液培养中均为阳性。常见的细菌为大肠埃希菌(31.3%)、肺炎克雷伯菌(26.9%)、金黄色葡萄球菌(8.2%)、流感嗜血杆菌(7.7%)、阴沟肠杆菌(7.1%)、肺炎链球菌(1.6%)、卡塔莫拉菌(2.2%)。药物敏感试验显示:大多细菌对青霉素耐药,对亚胺培南,美诺培南及万古霉素敏感。大肠埃希菌和肺炎克雷伯菌ES-BLs的产生率高。结论:大肠埃希菌,肺炎克雷伯菌,金黄色葡萄球菌,流感嗜血杆菌是新生儿肺炎患儿主要病原菌,对青霉素普遍耐药。 Objective To investigate the types and drug resistance of pathogenic bacteria in neonatal pneumonia. Methods:182 children with neonatal pneumonia were selected and the sputum specimens were sampled by negative pressure suction. The sputumbacterial culture and drug sensitivity tests were performed, and the common pathogenic microorganisms were pathogenically analyzed . Results: The results of the sputum bacterial culture of the 182 neonates were all positive, and the common bacteria wereEscherichia coli (31. 3 % ), Klebsiella pneumoniae (26. 9% ) , Staphylococcus aureus (8. 2% ) , Haemophilus influenzae (7. 7 % ),Enterobacter cloacae (7. 1 % ), Streptococcus pneumoniae ( 1. 6% ) , and Moraxella catarrhalis (2. 2 % ). The drug sensitive testshowed that most bacteria were resistant to Penicillin, Imipenem, Meropenem and Vancomycin. The production rate of Escherichia coliand klebsiella pneumoniae ES-BLs was high. Conclusions: Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, andHaemophilus influenzae are the main pathogenic bacteria of neonatal pneumonia, and resistant to Penicillin.
作者 林娟
出处 《中国民康医学》 2016年第15期12-13,共2页 Medical Journal of Chinese People’s Health
关键词 新生儿 肺炎 病原菌 耐药分析 Neonate Pneumonia Pathogenic bacteria Drug resistance analysis
  • 相关文献

参考文献2

二级参考文献13

  • 1黄越芳,庄思齐,陈东平,李易娟,陈玮琪,李晓瑜.新生儿重症监护室产超广谱β-内酰胺酶菌院内感染危险因素及耐药性分析[J].中国实用儿科杂志,2004,19(8):471-473. 被引量:12
  • 2李真,臧晓丽,刘颖,张亚莲.产超广谱β-内酰胺酶革兰阴性菌对12种抗菌药物耐药性分析[J].中华医院感染学杂志,2004,14(2):217-219. 被引量:55
  • 3郑亚芬,周惠娜,承晓京,魏梓文.新生儿医院产超广谱β-内酰胺酶肺炎克雷伯菌感染分离株耐药性及基因类型检测[J].中国抗生素杂志,2007,32(4):236-238. 被引量:4
  • 4张璟,孙自镛,马越,李景云,金少鸿.152株肺炎链球菌的耐药性及血清分型研究[J].中华医院感染学杂志,2007,17(4):468-471. 被引量:36
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Eighteenth informational supplement. CIGI documents M100-S18. CLSI/NCCLS,2008.
  • 6Granger D, Boily-Larouche G, Turgeon P, et al. Molecular characteristics of pbpla and pbp2b in clinical Streptococcus pneurnoniae isolates in Quebec. Canada[J]. J Antimierob Chemoter,2006,57(1):61-70.
  • 7Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamases-producing Enterobacteriaeeae[J]. Antimierob Agents Chemother, 2006,50(4) : 1257-1262.
  • 8Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-β-lactamases-producing Klebsiella pneumoniae :risk factors, molecular epidemiol- ogy and clinical outcome[J]. Antimicrob Agents Chemother, 2006,50(2):498 504.
  • 9Wang H, Kelkar S, Wu WY, etal. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases:prevalence of CTX-M 3 at a hospital in China[J]. Antimicrob Agents Chemother, 2003,47(2) : 790-793.
  • 10Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Seventh edition. Approved Standard. CLSI documents M7 A7. CLSI,2006.

共引文献307

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部